Physician profile
Joe Wilkinson
NPI 1003874033
$1,859.26
in general payments reported to CMS, 2019-2025
11 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $295 · 2021: $398 · 2022: $396 · 2023: $171 · 2024: $28.19 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,431.63 | 2019-2025 | Mako, Triathlon |
| Pfizer INC. | $69.65 | 2020-2021 | |
| Pacira Therapeutics, INC. | $67.16 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $58.06 | 2020-2021 | |
| Merz North America, INC. | $57.22 | 2022 | |
| Anika Therapeutics, INC. | $52.16 | 2021-2022 | |
| Pylant Medical | $38.32 | 2020 | |
| Depuy Synthes Sales INC. | $38.20 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $21.86 | 2020 | |
| Arthrosurface Incorporated | $13.13 | 2020 | |
| Convatec INC. | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.